NCT04625647: Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
- State
- Under way
- Phase
- Phase 2
- People
- 116 planned
- Started
- 16 Apr 2021
- Primary completion
- 31 Dec 2026
- Arms
- Treatment (AMG 510)
- Results
- None posted
- 12 Nov 2020: Trial registered
- 16 Apr 2021: Trial started